Percent change from baseline in leiomyoma size · patients with uterine leiomyomas
1 finding from 1 review
Size (cm3) of leiomyoma · patients with uterine leiomyomas
2 findings from 1 review
Percent change from baseline in leiomyoma size in GHRH‐analogue treated women · patients with uterine leiomyomas
1 finding from 1 review
Size (cm3) of leiomyoma · patients with uterine leiomyomas
2 findings from 1 review
Effect on later sexual function · Postmenopausal women
2 findings from 1 review
Effect on later sexual function · symptomatic or early postmenopausal women1.
2 findings from 1 review
Live birth rate · infertile women with polycystic ovary syndrome
Letrozole with or without adjuncts leads to higher live birth rate compared with SERMs with or without adjuncts followed by timed intercourse (high certainty).
1 finding from 1 review
OHSS · infertile women with polycystic ovary syndrome
Letrozole with or without adjuncts showed no clear difference in ovarian hyperstimulation syndrome rate compared with SERMs with or without adjuncts followed by timed intercourse (high certainty).
1 finding from 1 review
Clinical pregnancy rate · infertile women with polycystic ovary syndrome
Letrozole with or without adjuncts leads to higher clinical pregnancy rate compared with SERMs with or without adjuncts followed by timed intercourse (high certainty).
1 finding from 1 review
Miscarriage · infertile women with polycystic ovary syndrome
Letrozole with or without adjuncts showed no clear difference in miscarriage rate per pregnancy compared with SERMs with or without adjuncts followed by timed intercourse (high certainty).
1 finding from 1 review
Multiple pregnancy rate · infertile women with polycystic ovary syndrome
Letrozole with or without adjuncts showed no clear difference in multiple pregnancy rate compared with SERMs with or without adjuncts followed by timed intercourse (high certainty).
1 finding from 1 review
Relief of overall pain ‐ reported as pelvic pain ‐ 3 months · women with endometriosis, following complete surgical excision of lesions
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events ‐ pelvic pain · women with endometriosis, following complete surgical excision of lesions
It is very uncertain whether raloxifene changes adverse events ‐ pelvic pain compared with placebo (very low certainty).
1 finding from 1 review
Adverse events ‐ ovarian cyst · women with endometriosis, following complete surgical excision of lesions
It is very uncertain whether raloxifene changes adverse events ‐ ovarian cyst compared with placebo (very low certainty).
1 finding from 1 review
Adverse effects: headache · women with endometriosis, following complete surgical excision of lesions
It is very uncertain whether raloxifene changes adverse events ‐ headache compared with placebo (very low certainty).
1 finding from 1 review
Adverse events ‐ migraine · women with endometriosis, following complete surgical excision of lesions
It is very uncertain whether raloxifene changes adverse events ‐ migraine compared with placebo (very low certainty).
1 finding from 1 review
Adverse events ‐ depression · women with endometriosis, following complete surgical excision of lesions
It is very uncertain whether raloxifene changes adverse events ‐ depression compared with placebo (very low certainty).
1 finding from 1 review
Biopsy‐proven recurrence of endometriosis · women with endometriosis, following complete surgical excision of lesions
It is very uncertain whether raloxifene changes biopsy‐proven recurrence of endometriosis compared with placebo (very low certainty).
1 finding from 1 review